# Clinical trials recruiting in Idaho: 356 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 356 trials recruiting or not yet recruiting with a site in Idaho, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Idaho: 356 rows for $17.80, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 9 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/idaho

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 356
- Recruiting or not yet: 356
- Read on: November 19, 2026

## Trials

The 25 newest of 356, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 10, 2026 | NCT07927179 | Effects of Different Instrument Assisted Soft Tissue Mobilization Force Applications on Ankle Stiffness and Dorsiflexion | University of Idaho | Not applicable | Not yet recruiting | Range of Motion, Articular, Ankle Joint, High Force IASTM Treatment, Low Force IASTM Treatment, Control Condition With... | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927179) |
| October 29, 2026 | NCT07903675 | Effectiveness of the Autism Pupil Screen (APS) Detect Pupillometer for Identifying Autism Spectrum Disorder (ASD) in Routine Healthcare | Schweitzer Engineering Laboratories | Observational | Recruiting | Autism Spectrum Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903675) |
| October 22, 2026 | NCT07890376 | A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes | Eli Lilly and Company | Phase 2 | Not yet recruiting | Obesity, Overweight | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890376) |
| October 13, 2026 | NCT07871409 | Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight | Amgen | Phase 3 | Recruiting | Obesity, Overweight | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871409) |
| October 7, 2026 | NCT07864168 | Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes | Medtronic MiniMed, Inc. | Not applicable | Recruiting | Type 1 Diabetes, Type 2 Diabetes | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864168) |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861100) |
| October 1, 2026 | NCT07852728 | HBOT Effects on First Responders' Cognition and Well-Being | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder, Anxiety, Depression, Post Concussion Symptoms | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852728) |
| October 1, 2026 | NCT07851246 | A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age | GlaxoSmithKline | Phase 3 | Recruiting | Influenza, Human | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851246) |
| September 30, 2026 | NCT07849465 | Hyperbaric Oxygen Therapy for Veterans With TBI and PCS: A Biomarker Study | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury (TBI) Patients, Post Concussive Symptoms, PTSD | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849465) |
| September 28, 2026 | NCT07843498 | A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity | Hoffmann-La Roche | Phase 3 | Recruiting | Obesity or Overweight | 3,900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843498) |
| September 16, 2026 | NCT07822321 | Brexanolone Lifting Outcomes Of Moms | Lipocine Inc. | Phase 3 | Recruiting | Depression, Postpartum, Postpartum Depression (PPD), Post-partum Depression, Postnatal Depression, Post-Natal... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822321) |
| September 15, 2026 | NCT07819435 | Phase 2/3 Efficacy and Safety of PP405 in Adult Males | Pelage Pharmaceuticals, Inc. | Phase 2/3 | Recruiting | Androgenetic Alopecia | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07819435) |
| September 14, 2026 | NCT07819097 | A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults | Pfizer | Phase 3 | Recruiting | Adult, Healthy Participants | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07819097) |
| September 11, 2026 | NCT07816367 | A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | TriGemX Bio, Inc. | Phase 3 | Recruiting | Migraine | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816367) |
| September 4, 2026 | NCT07805707 | A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age | GlaxoSmithKline | Phase 3 | Recruiting | Influenza, Human | 54,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805707) |
| September 1, 2026 | NCT07797335 | AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People... | Novo Nordisk A/S | Phase 3 | Recruiting | Type 2 Diabetes, Cardiovascular Risk | 1,778 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797335) |
| August 31, 2026 | NCT07794579 | A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1... | Eli Lilly and Company | Phase 3 | Recruiting | Overweight, Prediabetic State, Prehypertension, Obesity, Abdominal | 2,001 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07794579) |
| August 24, 2026 | NCT07783425 | A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema | Pfizer | Phase 3 | Recruiting | Atopic Dermatitis | 1,375 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783425) |
| August 20, 2026 | NCT07775495 | Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure | Ecotera Health LLC | Observational | Recruiting | Healthy Adult Participants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775495) |
| August 19, 2026 | NCT07772492 | A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata | AbbVie | Phase 3 | Recruiting | Severe Alopecia Areata | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07772492) |
| August 14, 2026 | NCT07766499 | A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU) | Calixis Inc. | Phase 2 | Recruiting | Chronic Spontaneous Urticaria (CSU), Chronic Idiopathic Urticaria | 81 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766499) |
| August 11, 2026 | NCT07758140 | Comparative Self-collection for Cervical Cancer Screening Pivotal Study | Mel Mont Medical | Not applicable | Recruiting | HPV, HPV - Anogenital Human Papilloma Virus Infection | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758140) |
| August 10, 2026 | NCT07754461 | A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar | Boehringer Ingelheim | Phase 3 | Recruiting | Type 2 Diabetes | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754461) |
| August 7, 2026 | NCT07752979 | Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities | AbbVie | Phase 2 | Recruiting | Obesity, Overweight | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07752979) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Kootenai Health - Coeur d'Alene | Coeur d'Alene | 90 |
| Kootenai Clinic Cancer Services - Post Falls | Post Falls | 89 |
| Kootenai Clinic Cancer Services - Sandpoint | Sandpoint | 81 |
| Saint Luke's Cancer Institute - Boise | Boise | 81 |
| Saint Alphonsus Cancer Care Center-Nampa | Nampa | 77 |
| Saint Alphonsus Cancer Care Center-Boise | Boise | 71 |
| Saint Alphonsus Cancer Care Center-Caldwell | Caldwell | 69 |
| Saint Luke's Cancer Institute - Fruitland | Fruitland | 66 |
| Saint Luke's Cancer Institute - Meridian | Meridian | 66 |
| Saint Luke's Cancer Institute - Nampa | Nampa | 66 |
| Saint Luke's Cancer Institute - Twin Falls | Twin Falls | 47 |
| Idaho Urologic Institute-Meridian | Meridian | 40 |
| Walter Knox Memorial Hospital | Emmett | 24 |
| Solaris Clinical Research | Meridian | 10 |
| Medical Research Partners | Ammon | 9 |
| Treasure Valley Medical Research | Boise | 7 |
| Elite Clinical Trials | Blackfoot | 5 |
| Saint Alphonsus Regional Medical Center | Boise | 5 |
| St. Luke's Boise Medical Center | Boise | 5 |
| Rocky Mountain Clinical Research - Idaho Falls | Idaho Falls | 4 |
| Kootenai Cancer Clinic | Sandpoint | 4 |
| Clinical Research Prime | Rexburg | 4 |
| Grand Teton Research Group, PLLC | Idaho Falls | 4 |
| St. Luke's Cancer Institute: Boise | Boise | 3 |
| Consultants in Epilepsy and Neurology, PLLC | Boise | 3 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 2 |
| Phase 1/2 | 3 |
| Phase 2 | 87 |
| Phase 2/3 | 11 |
| Phase 3 | 181 |
| Phase 4 | 2 |
| Not applicable | 35 |
| Observational | 35 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Obesity | 26 |
| Overweight | 21 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Diabetes Mellitus, Type 2 | 16 |
| Prostatic Neoplasms | 14 |
| Lung Neoplasms | 12 |
| Leukemia, Myeloid, Acute | 9 |
| Colonic Neoplasms | 8 |
| Colorectal Neoplasms | 8 |
| Melanoma | 8 |
| Breast Neoplasms | 7 |
| Urinary Bladder Neoplasms | 7 |
| Heart Failure | 6 |
| Burkitt Lymphoma | 6 |
| Respiratory Distress Syndrome | 6 |
| Cardiovascular Diseases | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Depression | 5 |
| Neoplasm Metastasis | 5 |
| Rectal Neoplasms | 5 |
| Myelodysplastic Syndromes | 5 |
| Colitis, Ulcerative | 5 |
| Influenza, Human | 5 |
| Hypertension | 4 |
| Epilepsy | 4 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 45 |
| SWOG Cancer Research Network | 22 |
| Alliance for Clinical Trials in Oncology | 21 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 19 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 16 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 13 |
| Children's Oncology Group | 12 |
| NRG Oncology | 10 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 8 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 8 |
| ECOG-ACRIN Cancer Research Group | 8 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 6 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 6 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 6 |
| [Boston Scientific Corporation](https://specstream.ai/data/clinical-trials/company/boston-scientific-corporation) | 6 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 5 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 5 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 4 |
| PPD Development, LP | 4 |
| University of Idaho | 4 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 3 |
| [Vertex Pharmaceuticals Incorporated](https://specstream.ai/data/clinical-trials/company/vertex-pharmaceuticals-incorporated) | 3 |
| Canadian Cancer Trials Group | 3 |
| [Sun Pharmaceutical Industries, Inc.](https://specstream.ai/data/clinical-trials/company/sun-pharmaceutical-industries-inc) | 2 |
| Rapport Therapeutics Inc. | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Idaho

- [Vocational and technical schools in Idaho, United States](https://specstream.ai/data/businesses/vocational-and-technical-schools/idaho-united-states)
- [Pediatric clinics in Idaho, United States](https://specstream.ai/data/businesses/pediatric-clinics/idaho-united-states)
- [Home cleaning companies in Idaho, United States](https://specstream.ai/data/businesses/home-cleaning-companies/idaho-united-states)
- [Civil engineering firms in Idaho, United States](https://specstream.ai/data/businesses/civil-engineering-firms/idaho-united-states)
- [Trucking companies in Idaho, United States](https://specstream.ai/data/businesses/trucking-companies/idaho-united-states)
- [Orthopedics practices in Idaho, United States](https://specstream.ai/data/businesses/orthopedics-practices/idaho-united-states)
